Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1972
|
| gptkbp:ATCCode |
J01CA04
|
| gptkbp:brand |
gptkb:amoxicillin
|
| gptkbp:CASNumber |
26787-78-0
|
| gptkbp:chemicalFormula |
C16H19N3O5S
|
| gptkbp:contraindication |
allergy to penicillins
|
| gptkbp:discoveredBy |
gptkb:Beecham_Group
|
| gptkbp:drugClass |
gptkb:antibiotic
|
| gptkbp:eliminationHalfLife |
1-1.5 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:form |
gptkb:tablet
capsule oral suspension |
| https://www.w3.org/2000/01/rdf-schema#label |
Amoxil
|
| gptkbp:indication |
gptkb:sinusitis
gptkb:pneumonia urinary tract infection otitis media skin infection throat infection |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea rash |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Amoxicillin
|
| gptkbp:bfsLayer |
5
|